v3 Template
R

Radiant Biotherapeutics

Biotechnology Chicago, USA ~10 employees
Founded
--
Employees (Est.)
~10
1 leaders known
Total Funding
$35.0M
Funding Rounds
1
Last Funding
2024-09-11

About Radiant Biotherapeutics

Radiant Biotherapeutics is focused on advancing a modular multi-valent and multi-specific platform based on breakthrough antibody engineering to deliver potent multi-functional biologics for treating difficult diseases such as cancer, auto-immune, and infectious diseases.

Products & Services

Multabody Platform:A multi-specific, multi-affinity antibody platform utilizing a human self-multimerizing scaffold (apoferritin) to multimerize antibody fragments. It leverages avidity and multi-specificity to create potent, modular biologics with antibody-like developability and pharmacokinetics, aimed at unlocking cures for patients.

Specialties

Antibody Engineering Multi-specific Biologics Multi-valent Platforms Cancer Treatment Auto-immune Disease Treatment Infectious Disease Treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 35000000
MR: -
FA: $35 million
FAN: 35000000 		D: 2024-09-11
FD: 2024-09-11 		7 investors
Series A Latest
2024-09-11
$35.0M
7 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Deborah Geraghty

President and Chief Executive Officer

Recent News

Radiant Biotherapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~10 employees (est.)
Locations
Chicago, USA

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro